For the quarter ending 2026-03-31, JANX has $1,028,225K in assets. $86,690K in debts. $51,828K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 51,828 | 52,334 | 48,389 | 52,446 |
| Accounts receivable, net | 35,000 | - | - | - |
| Short-term investments | 904,558 | 914,233 | 940,604 | 943,565 |
| Prepaid expenses and other current assets | 10,663 | 9,320 | 9,093 | 9,542 |
| Total current assets | 1,002,049 | 975,887 | 998,086 | 1,005,553 |
| Restricted cash | 816 | 816 | 816 | 816 |
| Total property and equipment | 10,898 | 10,819 | 10,813 | - |
| Less accumulated depreciation | 7,352 | 6,967 | 6,499 | - |
| Property and equipment, net | 3,546 | 3,852 | 4,314 | 4,688 |
| Operating lease right-of-use assets | 17,870 | 18,402 | 18,923 | 18,462 |
| Other long-term assets | 3,944 | 2,608 | 2,627 | 2,693 |
| Total assets | 1,028,225 | 1,001,565 | 1,024,766 | 1,032,212 |
| Accounts payable | 3,376 | 4,971 | 3,395 | 3,477 |
| Accrued expenses | 15,476 | 17,633 | 22,156 | 16,029 |
| Current portion of deferred revenue | 37,591 | - | - | - |
| Current portion of operating lease liabilities | 2,472 | 2,393 | 2,280 | 1,873 |
| Total current liabilities | 58,915 | 24,997 | 27,831 | 21,379 |
| Deferred revenue, net of current portion | 8,676 | - | - | - |
| Operating lease liabilities, net of current portion | 19,099 | 19,746 | 20,380 | 20,317 |
| Total liabilities | 86,690 | 44,743 | 48,211 | 41,696 |
| Common stock, 0.001 par value authorized shares - 200,000,000 at march 31, 2026 and december 31, 2025 issued and outstanding shares - 60,865,458 and 60,384,283 at march 31, 2026 and december 31, 2025, respectively | 60 | 60 | 60 | 59 |
| Additional paid-in capital | 1,316,642 | 1,303,828 | 1,291,369 | 1,281,833 |
| Accumulated other comprehensive income | 576 | 4,316 | 4,562 | 3,747 |
| Accumulated deficit | -375,743 | -351,382 | -319,436 | -295,123 |
| Total stockholders' equity | 941,535 | 956,822 | 976,555 | 990,516 |
| Total liabilities and stockholders' equity | 1,028,225 | 1,001,565 | 1,024,766 | 1,032,212 |
Janux Therapeutics, Inc. (JANX)
Janux Therapeutics, Inc. (JANX)